Court's decision likely good for patients, but gene-patent ruling leaves many questions unanswered
Women with a family history of breast cancer, or with breast cancer themselves, are likely cheering the June 12 ruling by the U.S. Supreme Court, which found that patents granted to Myriad Genetics Inc. for ...
18 hours ago
not rated yet |
0
not rated yet |
0
